Global Infusion Therapy Market Opportunities and Forecast 2023-2030
- DLR2676
- 21 July, 2021
- Pharma & Healthcare
- Pages: 120
- Global
Global Infusion Therapy Market, By Type (Intravenous, Epidural, Intramuscular, Subcutaneous), By Product (Intravenous Set, Needleless Catheter, Infusion Pump, Accessories), By Application (Antibiotic/Antiviral, Anti-Coagulation Therapy, Anti-Emetics, Anti-Hemophilic Factors, Blood Factor, Chemotherapy, Diabetes, Enteral Nutrition, Hydration, Inotropic Therapy, Pain Management, Total Parenteral Nutrition, Others), By End-user(Hospitals & Clinics, Infusion Therapy Centers, Home Care, Others), and opportunities and forecast 2023-2030.
Infusion Therapy Market Overview
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications. Infusion therapy is used in the treatment of rheumatoid arthritis, Crohn’s disease, immune deficiencies, hemophilia, and multiple sclerosis. Thus, increasing application areas of infusion therapy creates a noteworthy opportunity for companies to expand their services. This major factor is projected to boost the global infusion therapy market.
Moreover, an increasing number of people suffering from chronic pain, cancer, and diabetes is a key driver of the global infusion therapy market. The International Agency for Research on Cancer released new estimates on the global cancer burden, indicating that it has risen to 19.3 million cases and 10 million cancer deaths in 2020. In addition, as per World Health Organization, in 2019, an estimated 1.5 million deaths were directly caused by diabetes.
Furthermore, governments in developing countries are investing significantly to improve healthcare infrastructure. This is expected to increase the demand for infusion therapy services. Eventually, it rises the growth of the market.
However, the high costs of devices and treatment may hamper the growth of the Infusion Therapy market. As well, the increasing prevalence of chronic diseases in developing countries presents lucrative opportunities in the global infusion therapy market.
Covid-19 Impact on Infusion Therapy Market:
In addition, the current Infusion Therapy Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Infusion Therapy Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Infusion Therapy Market Segment Overview
Based on application, the Chemotherapy segment is projected to witness the fastest growth during the forecast period. This can be attributed to the increasing prevalence of cancer and the subsequent rise in the demand for chemotherapy is anticipated to boost the market growth significantly. Moreover, by end-user, Homecare is estimated to be the fastest-growing segment during the forecast period. The rapid developments in infusion therapy technologies have facilitated the alternative of receiving infusion therapy in homecare settings. In addition to this, the easy use of infusion therapy devices which also allow for precise monitoring of the patients in the comfort of their homes has led to the rapid growth of this particular segment.
Infusion Therapy Market, By Type
· Intravenous
· Epidural
· Intramuscular
· Subcutaneous
Infusion Therapy Market, By Product
· Intravenous Set
· Needleless Catheter
· Infusion Pump
· Accessories
Infusion Therapy Market, By Application
· Antibiotic/Antiviral
· Anti-Coagulation Therapy
· Anti-Emetics
· Anti-Hemophilic Factors
· Blood Factor
· Chemotherapy
· Diabetes
· Enteral Nutrition
· Hydration
· Inotropic Therapy
· Pain Management
· Total Parenteral Nutrition
· Others
Infusion Therapy Market, By End-user
· Hospitals & Clinics
· Infusion Therapy Centers
· Home Care
· Others
Infusion Therapy Market Regional Overview
In terms of region, North America is anticipated to dominate the overall market, throughout the forecast period. This is due to the high incidence rate of chronic diseases such as diabetes and cardiovascular diseases in this region. Similarly, Europe is likely to be the second-largest market during the forecast period. The technological progressions and increasing investments by pharmaceutical companies in the infusion therapy business are majorly support to the development of the market in this region. Also, the infusion therapy market in the Asia Pacific is projected to expand at a rapid pace during the forecast period owing to a rise in healthcare infrastructure in this region. Likewise, the market in Latin America and Middle East & Africa is projected to expand at a steady pace due to a rise in the demand for low-cost infusion therapy in these regions.
Infusion Therapy Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Infusion Therapy Market, Key Players
· Becton, Dickinson, and company
· Terumo Medical Corporation
· Nipro Europe Group Companies
· B. Braun Melsungen AG
· ICU Medical, Inc.
· Medtronic PLC
· Poly Medicure Limited
· Fresenius SE & Co. KGaA
· BIO-MED
· Mediprim GmbH
· Baxter International
· Micrel Medical Devices SA
· Smith’s Medical
· Vygon SA
· Argon Medical Devices, Inc.
Infusion Therapy Market Overview
Infusion therapy involves the administration of medication through a needle or catheter. It is prescribed when a patient’s condition is so severe that it cannot be treated effectively by oral medications. Infusion therapy is used in the treatment of rheumatoid arthritis, Crohn’s disease, immune deficiencies, hemophilia, and multiple sclerosis. Thus, increasing application areas of infusion therapy creates a noteworthy opportunity for companies to expand their services. This major factor is projected to boost the global infusion therapy market.
Moreover, an increasing number of people suffering from chronic pain, cancer, and diabetes is a key driver of the global infusion therapy market. The International Agency for Research on Cancer released new estimates on the global cancer burden, indicating that it has risen to 19.3 million cases and 10 million cancer deaths in 2020. In addition, as per World Health Organization, in 2019, an estimated 1.5 million deaths were directly caused by diabetes.
Furthermore, governments in developing countries are investing significantly to improve healthcare infrastructure. This is expected to increase the demand for infusion therapy services. Eventually, it rises the growth of the market.
However, the high costs of devices and treatment may hamper the growth of the Infusion Therapy market. As well, the increasing prevalence of chronic diseases in developing countries presents lucrative opportunities in the global infusion therapy market.
Covid-19 Impact on Infusion Therapy Market:
In addition, the current Infusion Therapy Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Infusion Therapy Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Infusion Therapy Market Segment Overview
Based on application, the Chemotherapy segment is projected to witness the fastest growth during the forecast period. This can be attributed to the increasing prevalence of cancer and the subsequent rise in the demand for chemotherapy is anticipated to boost the market growth significantly. Moreover, by end-user, Homecare is estimated to be the fastest-growing segment during the forecast period. The rapid developments in infusion therapy technologies have facilitated the alternative of receiving infusion therapy in homecare settings. In addition to this, the easy use of infusion therapy devices which also allow for precise monitoring of the patients in the comfort of their homes has led to the rapid growth of this particular segment.
Infusion Therapy Market, By Type
· Intravenous
· Epidural
· Intramuscular
· Subcutaneous
Infusion Therapy Market, By Product
· Intravenous Set
· Needleless Catheter
· Infusion Pump
· Accessories
Infusion Therapy Market, By Application
· Antibiotic/Antiviral
· Anti-Coagulation Therapy
· Anti-Emetics
· Anti-Hemophilic Factors
· Blood Factor
· Chemotherapy
· Diabetes
· Enteral Nutrition
· Hydration
· Inotropic Therapy
· Pain Management
· Total Parenteral Nutrition
· Others
Infusion Therapy Market, By End-user
· Hospitals & Clinics
· Infusion Therapy Centers
· Home Care
· Others
Infusion Therapy Market Regional Overview
In terms of region, North America is anticipated to dominate the overall market, throughout the forecast period. This is due to the high incidence rate of chronic diseases such as diabetes and cardiovascular diseases in this region. Similarly, Europe is likely to be the second-largest market during the forecast period. The technological progressions and increasing investments by pharmaceutical companies in the infusion therapy business are majorly support to the development of the market in this region. Also, the infusion therapy market in the Asia Pacific is projected to expand at a rapid pace during the forecast period owing to a rise in healthcare infrastructure in this region. Likewise, the market in Latin America and Middle East & Africa is projected to expand at a steady pace due to a rise in the demand for low-cost infusion therapy in these regions.
Infusion Therapy Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Infusion Therapy Market, Key Players
· Becton, Dickinson, and company
· Terumo Medical Corporation
· Nipro Europe Group Companies
· B. Braun Melsungen AG
· ICU Medical, Inc.
· Medtronic PLC
· Poly Medicure Limited
· Fresenius SE & Co. KGaA
· BIO-MED
· Mediprim GmbH
· Baxter International
· Micrel Medical Devices SA
· Smith’s Medical
· Vygon SA
· Argon Medical Devices, Inc.
Infusion Therapy Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Infusion Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Intravenous
- 5.2.2. Epidural
- 5.2.3. Intramuscular
- 5.2.4. Subcutaneous
- 5.3. Market Analysis, Insights and Forecast – By Product
- 5.3.1. Intravenous Set
- 5.3.2. Needleless Catheter
- 5.3.3. Infusion Pump
- 5.3.4. Accessories
- 5.4. Market Analysis, Insights and Forecast – By Application
- 5.4.1. Antibiotic/Antiviral
- 5.4.2. Anti-Coagulation Therapy
- 5.4.3. Anti-Emetics
- 5.4.4. Anti-Hemophilic Factors
- 5.4.5. Blood Factor
- 5.4.6. Chemotherapy
- 5.4.7. Diabetes
- 5.4.8. Enteral Nutrition
- 5.4.9. Hydration
- 5.4.10. Inotropic Therapy
- 5.4.11. Pain Management
- 5.4.12. Total Parenteral Nutrition
- 5.4.13. Others
- 5.5. Market Analysis, Insights and Forecast – By End-user
- 5.5.1. Hospitals & Clinics
- 5.5.2. Infusion Therapy Centers
- 5.5.3. Home Care
- 5.5.4. Others
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America, Middle East and Africa
6. North America Infusion Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Intravenous
- 6.2.2. Epidural
- 6.2.3. Intramuscular
- 6.2.4. Subcutaneous
- 6.3. Market Analysis, Insights and Forecast – By Product
- 6.3.1. Intravenous Set
- 6.3.2. Needleless Catheter
- 6.3.3. Infusion Pump
- 6.3.4. Accessories
- 6.4. Market Analysis, Insights and Forecast – By Application
- 6.4.1. Antibiotic/Antiviral
- 6.4.2. Anti-Coagulation Therapy
- 6.4.3. Anti-Emetics
- 6.4.4. Anti-Hemophilic Factors
- 6.4.5. Blood Factor
- 6.4.6. Chemotherapy
- 6.4.7. Diabetes
- 6.4.8. Enteral Nutrition
- 6.4.9. Hydration
- 6.4.10. Inotropic Therapy
- 6.4.11. Pain Management
- 6.4.12. Total Parenteral Nutrition
- 6.4.13. Others
- 6.5. Market Analysis, Insights and Forecast – By End-user
- 6.5.1. Hospitals & Clinics
- 6.5.2. Infusion Therapy Centers
- 6.5.3. Home Care
- 6.5.4. Others
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Europe Infusion Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Intravenous
- 7.2.2. Epidural
- 7.2.3. Intramuscular
- 7.2.4. Subcutaneous
- 7.3. Market Analysis, Insights and Forecast – By Product
- 7.3.1. Intravenous Set
- 7.3.2. Needleless Catheter
- 7.3.3. Infusion Pump
- 7.3.4. Accessories
- 7.4. Market Analysis, Insights and Forecast – By Application
- 7.4.1. Antibiotic/Antiviral
- 7.4.2. Anti-Coagulation Therapy
- 7.4.3. Anti-Emetics
- 7.4.4. Anti-Hemophilic Factors
- 7.4.5. Blood Factor
- 7.4.6. Chemotherapy
- 7.4.7. Diabetes
- 7.4.8. Enteral Nutrition
- 7.4.9. Hydration
- 7.4.10. Inotropic Therapy
- 7.4.11. Pain Management
- 7.4.12. Total Parenteral Nutrition
- 7.4.13. Others
- 7.5. Market Analysis, Insights and Forecast – By End-user
- 7.5.1. Hospitals & Clinics
- 7.5.2. Infusion Therapy Centers
- 7.5.3. Home Care
- 7.5.4. Others
- 7.6. Market Analysis, Insights and Forecast – By Country
- 7.6.1. UK
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Italy
- 7.6.5. Spain
- 7.6.6. Russia
- 7.6.7. Rest of Europe
8. Asia Pacific Infusion Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Intravenous
- 8.2.2. Epidural
- 8.2.3. Intramuscular
- 8.2.4. Subcutaneous
- 8.3. Market Analysis, Insights and Forecast – By Product
- 8.3.1. Intravenous Set
- 8.3.2. Needleless Catheter
- 8.3.3. Infusion Pump
- 8.3.4. Accessories
- 8.4. Market Analysis, Insights and Forecast – By Application
- 8.4.1. Antibiotic/Antiviral
- 8.4.2. Anti-Coagulation Therapy
- 8.4.3. Anti-Emetics
- 8.4.4. Anti-Hemophilic Factors
- 8.4.5. Blood Factor
- 8.4.6. Chemotherapy
- 8.4.7. Diabetes
- 8.4.8. Enteral Nutrition
- 8.4.9. Hydration
- 8.4.10. Inotropic Therapy
- 8.4.11. Pain Management
- 8.4.12. Total Parenteral Nutrition
- 8.4.13. Others
- 8.5. Market Analysis, Insights and Forecast – By End-user
- 8.5.1. Hospitals & Clinics
- 8.5.2. Infusion Therapy Centers
- 8.5.3. Home Care
- 8.5.4. Others
- 8.6. Market Analysis, Insights and Forecast – By Country
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. Australia
- 8.6.5. South East Asia
- 8.6.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Infusion Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Intravenous
- 9.2.2. Epidural
- 9.2.3. Intramuscular
- 9.2.4. Subcutaneous
- 9.3. Market Analysis, Insights and Forecast – By Product
- 9.3.1. Intravenous Set
- 9.3.2. Needleless Catheter
- 9.3.3. Infusion Pump
- 9.3.4. Accessories
- 9.4. Market Analysis, Insights and Forecast – By Application
- 9.4.1. Antibiotic/Antiviral
- 9.4.2. Anti-Coagulation Therapy
- 9.4.3. Anti-Emetics
- 9.4.4. Anti-Hemophilic Factors
- 9.4.5. Blood Factor
- 9.4.6. Chemotherapy
- 9.4.7. Diabetes
- 9.4.8. Enteral Nutrition
- 9.4.9. Hydration
- 9.4.10. Inotropic Therapy
- 9.4.11. Pain Management
- 9.4.12. Total Parenteral Nutrition
- 9.4.13. Others
- 9.5. Market Analysis, Insights and Forecast – By End-user
- 9.5.1. Hospitals & Clinics
- 9.5.2. Infusion Therapy Centers
- 9.5.3. Home Care
- 9.5.4. Others
- 9.6. Market Analysis, Insights and Forecast – By Country
- 9.6.1. Brazil
- 9.6.2. Saudi Arabia
- 9.6.3. UAE
- 9.6.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Becton, Dickinson and company
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Terumo Medical Corporation
- 10.6. Nipro Europe Group Companies
- 10.7. B. Braun Melsungen AG
- 10.8. ICU Medical, Inc.
- 10.9. Medtronic PLC
- 10.10. Poly Medicure Limited
- 10.11. Fresenius SE & Co. KGaA
- 10.12. BIO-MED
- 10.13. Mediprim GmbH
- 10.14. Baxter International
- 10.15. Micrel Medical Devices SA
- 10.16. Smith’s Medical
- 10.17. Vygon SA
Report You Might be Interested
Choose License Type
- USD
- GBP
- EURO
- INR
